Division of Hepatopancreatobiliary, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.
J Am Coll Surg. 2021 Sep;233(3):415-425. doi: 10.1016/j.jamcollsurg.2021.04.033. Epub 2021 May 21.
Morbidity after hepatectomy remains a significant, potentially preventable, outcome. Understanding the pattern of complications and rescue pathways is critical for the development of targeted initiatives intended to salvage patients after operative morbidity.
Patients undergoing liver resection from 1991 to 2018 at a single institution were analyzed. Failure to rescue (FTR) was defined as percentage of deaths in patients with a complication within 30 days. Generalized estimating equations with log-link function assessed associations between clinical characteristics and major complications and between complications at fewer than 30 days and 30 to 90 days. Logistic regression assessed associations between complications and FTR.
A total of 6,191 patients and 6,668 operations were identified, of which 55.6% were performed for management of metastatic colorectal cancer. Major complications (grade ≥3) occurred in 20.2% of operations (1,346 of 6,668). Ninety-day mortality was 2.2%. The most common complication was intra-abdominal abscess at 9.0% (95% CI, 8.3% to 9.7%). Ten percent of patients with a complication at 30 days had another complication between 30 and 90 days compared with 2% without an early complication (odds ratio [OR] 5.09; 95% CI, 3.97 to 6.54; p < 0.001). FTR for liver failure, cardiac arrest, abscess, and hemorrhage was 36%, 56%, 3%, and 6%, respectively. Risk of 90-day mortality was higher in patients with liver failure (53% vs 2%; OR 61.42; 95% CI, 37.47 to 100.67; p < 0.001), cardiac arrest (69% vs 2%; OR 96.95; 95% CI, 33.23 to 283.80; p < 0.001), hemorrhage (11% vs 2%; OR 5.51; 95% CI, 2.59 to 11.73; p < 0.001), and abscess (7% vs 2%; OR 4.05; 95% CI, 2.76 to 5.94; p < 0.001) compared with those without these complications.
Morbidity after hepatectomy is frequent despite low mortality. This study identifies targets for improvement in morbidity and failure to rescue after hepatectomy. Efforts to improve recognition and intervention for infections and early complications are needed to improve outcomes.
肝切除术后的发病率仍然是一个重大的、潜在可预防的结局。了解并发症的模式和抢救途径对于制定针对术后发病率的有针对性的抢救措施至关重要。
对单中心 1991 年至 2018 年间接受肝切除术的患者进行了分析。在 30 天内发生并发症的患者中,抢救失败(FTR)定义为死亡人数的百分比。采用对数链接函数的广义估计方程评估了临床特征与主要并发症之间以及 30 天内和 30 至 90 天之间并发症之间的关联。Logistic 回归评估了并发症与 FTR 之间的关联。
共确定了 6191 例患者和 6668 例手术,其中 55.6%是为治疗转移性结直肠癌而进行的。主要并发症(≥3 级)发生在 20.2%的手术(1346/6668)中。90 天死亡率为 2.2%。最常见的并发症是腹腔脓肿,占 9.0%(95%CI,8.3%至 9.7%)。与无早期并发症的患者相比,30 天有并发症的患者中有 10%在 30 至 90 天之间出现了另一种并发症(优势比[OR]5.09;95%CI,3.97 至 6.54;p<0.001)。肝衰竭、心脏骤停、脓肿和出血的 FTR 分别为 36%、56%、3%和 6%。肝衰竭(53% vs 2%;OR 61.42;95%CI,37.47 至 100.67;p<0.001)、心脏骤停(69% vs 2%;OR 96.95;95%CI,33.23 至 283.80;p<0.001)、出血(11% vs 2%;OR 5.51;95%CI,2.59 至 11.73;p<0.001)和脓肿(7% vs 2%;OR 4.05;95%CI,2.76 至 5.94;p<0.001)患者的 90 天死亡率均高于无这些并发症的患者。
尽管死亡率较低,但肝切除术后的发病率仍然很高。本研究确定了肝切除术后发病率和抢救失败的改进目标。需要努力提高对感染和早期并发症的认识和干预,以改善结局。